SCREENING PARADIGM FOR ?-THALASSEMIA CARRIERS; FROM CLINICAL TO MOLECULAR
? thalassemia (?-thal) represents a major health problem worldwide and particularly in Egypt. Its prevention, when compared to treatment, is found to be cost-effective, possible and practical. This work aimed to evaluate the effectiveness of diagnostic techniques in detection of the ?-thalassemia c...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2014-08-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | https://mjhid.org/index.php/mjhid/article/view/1736 |
id |
doaj-dfd109365dbd44a1958c3f30cf814446 |
---|---|
record_format |
Article |
spelling |
doaj-dfd109365dbd44a1958c3f30cf8144462020-11-25T03:26:08ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062014-08-011SCREENING PARADIGM FOR ?-THALASSEMIA CARRIERS; FROM CLINICAL TO MOLECULARIbrahim Youssef0soha youssef1Galila Mokhtar2Mahira I. Elmogy3Hanan M. Mahmoud4maryse soliman ayoub5Shaimaa A. Pessar6Ain Shams UniversityProfessor of clinical pathology Ain shams universityAin-Shams universityAin shams universityAin shams universityass.profAin shams university ? thalassemia (?-thal) represents a major health problem worldwide and particularly in Egypt. Its prevention, when compared to treatment, is found to be cost-effective, possible and practical. This work aimed to evaluate the effectiveness of diagnostic techniques in detection of the ?-thalassemia carrier state. The present work included 1627 child and adolescent of both sexes presenting as outpatients to clinics of Ain-Shams University Hospitals during period from 1/11/2009 to 30/6/2010. In the first phase microcytic hypochromic for age CBCs were selected. In the second phase, Iron profile and HPLC testing were performed. Molecular characterization by PCR reverse hybridization for detection of 22 common ?-globin gene mutations was done as a final step. The 280 Microcytic hypochromic cases selected were further analyzed by iron profile & HPLC. This revealed 100 suspected cases in whom a Hb A2 >4% was able to identify ? thalassemia carriers with 97.4% sensitivity, 72.7% specificity and 92% diagnostic accuracy while a HbA2 borderline value from 3.6% to 4% provided 100% sensitivity & 70% diagnostic accuracy. Further genotyping of the latter group confirmed presence of Beta thalassemia related mutations in 74% of the suspected cases. Conclusion: In addition to HPLC, as a reliable primary screening tool for ?-thalassemia trait (?TT), molecular testing is mandatory for selected cases with borderline Hb A2 values. https://mjhid.org/index.php/mjhid/article/view/1736anemiathalassemia |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ibrahim Youssef soha youssef Galila Mokhtar Mahira I. Elmogy Hanan M. Mahmoud maryse soliman ayoub Shaimaa A. Pessar |
spellingShingle |
Ibrahim Youssef soha youssef Galila Mokhtar Mahira I. Elmogy Hanan M. Mahmoud maryse soliman ayoub Shaimaa A. Pessar SCREENING PARADIGM FOR ?-THALASSEMIA CARRIERS; FROM CLINICAL TO MOLECULAR Mediterranean Journal of Hematology and Infectious Diseases anemia thalassemia |
author_facet |
Ibrahim Youssef soha youssef Galila Mokhtar Mahira I. Elmogy Hanan M. Mahmoud maryse soliman ayoub Shaimaa A. Pessar |
author_sort |
Ibrahim Youssef |
title |
SCREENING PARADIGM FOR ?-THALASSEMIA CARRIERS; FROM CLINICAL TO MOLECULAR |
title_short |
SCREENING PARADIGM FOR ?-THALASSEMIA CARRIERS; FROM CLINICAL TO MOLECULAR |
title_full |
SCREENING PARADIGM FOR ?-THALASSEMIA CARRIERS; FROM CLINICAL TO MOLECULAR |
title_fullStr |
SCREENING PARADIGM FOR ?-THALASSEMIA CARRIERS; FROM CLINICAL TO MOLECULAR |
title_full_unstemmed |
SCREENING PARADIGM FOR ?-THALASSEMIA CARRIERS; FROM CLINICAL TO MOLECULAR |
title_sort |
screening paradigm for ?-thalassemia carriers; from clinical to molecular |
publisher |
PAGEPress Publications |
series |
Mediterranean Journal of Hematology and Infectious Diseases |
issn |
2035-3006 |
publishDate |
2014-08-01 |
description |
? thalassemia (?-thal) represents a major health problem worldwide and particularly in Egypt. Its prevention, when compared to treatment, is found to be cost-effective, possible and practical. This work aimed to evaluate the effectiveness of diagnostic techniques in detection of the ?-thalassemia carrier state.
The present work included 1627 child and adolescent of both sexes presenting as outpatients to clinics of Ain-Shams University Hospitals during period from 1/11/2009 to 30/6/2010. In the first phase microcytic hypochromic for age CBCs were selected. In the second phase, Iron profile and HPLC testing were performed. Molecular characterization by PCR reverse hybridization for detection of 22 common ?-globin gene mutations was done as a final step.
The 280 Microcytic hypochromic cases selected were further analyzed by iron profile & HPLC. This revealed 100 suspected cases in whom a Hb A2 >4% was able to identify ? thalassemia carriers with 97.4% sensitivity, 72.7% specificity and 92% diagnostic accuracy while a HbA2 borderline value from 3.6% to 4% provided 100% sensitivity & 70% diagnostic accuracy. Further genotyping of the latter group confirmed presence of Beta thalassemia related mutations in 74% of the suspected cases.
Conclusion: In addition to HPLC, as a reliable primary screening tool for ?-thalassemia trait (?TT), molecular testing is mandatory for selected cases with borderline Hb A2 values.
|
topic |
anemia thalassemia |
url |
https://mjhid.org/index.php/mjhid/article/view/1736 |
work_keys_str_mv |
AT ibrahimyoussef screeningparadigmforthalassemiacarriersfromclinicaltomolecular AT sohayoussef screeningparadigmforthalassemiacarriersfromclinicaltomolecular AT galilamokhtar screeningparadigmforthalassemiacarriersfromclinicaltomolecular AT mahiraielmogy screeningparadigmforthalassemiacarriersfromclinicaltomolecular AT hananmmahmoud screeningparadigmforthalassemiacarriersfromclinicaltomolecular AT marysesolimanayoub screeningparadigmforthalassemiacarriersfromclinicaltomolecular AT shaimaaapessar screeningparadigmforthalassemiacarriersfromclinicaltomolecular |
_version_ |
1724593943960616960 |